AstraZeneca plc 14.3% Potential Decrease Indicated by DZ Bank

Broker Ratings
[shareaholic app="share_buttons" id_name="post_below_content"]

AstraZeneca plc using EPIC/TICKER code (LON:AZN) has had its stock rating noted as ‘Reiterates’ with the recommendation being set at ‘SELL’ today by analysts at DZ Bank. AstraZeneca plc are listed in the Health Care sector within UK Main Market. DZ Bank have set a target price of 7500 GBX on its stock. This would imply the analyst believes there is a potential downside of -14.3% from today’s opening price of 8748 GBX. Over the last 30 and 90 trading days the company share price has increased 297 points and increased 468 points respectively. The 1 year high for the share price is 10120 GBX while the year low stock price is currently 5871 GBX.

AstraZeneca plc has a 50 day moving average of 8,756.71 GBX and the 200 Day Moving Average price is recorded at 7,936.70. There are currently 1,312,271,081 shares in issue with the average daily volume traded being 2,165,616. Market capitalisation for LON:AZN is £114,981,192,117 GBP.

Twitter
LinkedIn
Facebook
Email
Reddit
Telegram
WhatsApp
Pocket
Find more news, interviews, share price & company profile here for:
    AstraZeneca's Tagrisso gains EU approval for treating advanced NSCLC, showing significant efficacy in reducing disease progression in key trials.
    AstraZeneca's Imfinzi receives FDA approval for limited-stage small cell lung cancer, marking a significant breakthrough in extending patient survival.
    AstraZeneca Plc commits $3.5 billion to boost US research and manufacturing by 2026, creating jobs and expanding its innovation footprint.

      Search

      Search